Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126788611 | 12678861 | 1 | I | 20160704 | 20160817 | 20160824 | 20160824 | EXP | IT-ASTRAZENECA-2016SE88650 | ASTRAZENECA | 27689.00 | DY | M | Y | 0.00000 | 20160824 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126788611 | 12678861 | 1 | PS | MERREM | MEROPENEM | 1 | Intravenous (not otherwise specified) | Y | U | 50706 | 6 | G | SOLUTION FOR INJECTION | QD | |||||
| 126788611 | 12678861 | 2 | SS | MERREM | MEROPENEM | 1 | Intravenous (not otherwise specified) | 2G/100 ML (SALINE SOLUTION) 3 TIMES A DAY | Y | U | 50706 | SOLUTION FOR INJECTION | |||||||
| 126788611 | 12678861 | 3 | SS | DECADRON | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 84 | MG | Y | U | 0 | 12 | MG | QD | ||||
| 126788611 | 12678861 | 4 | SS | ZYVOXID | LINEZOLID | 1 | Intravenous (not otherwise specified) | 8400 | MG | Y | U | 0 | 1200 | MG | QD | ||||
| 126788611 | 12678861 | 5 | SS | LEVOXACIN | LEVOFLOXACIN | 1 | Intravenous (not otherwise specified) | 6000 | MG | Y | U | 0 | 1000 | MG | QD | ||||
| 126788611 | 12678861 | 6 | C | FLUIMUCIL | ACETYLCYSTEINE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 126788611 | 12678861 | 7 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | Subcutaneous | 4000.0IU UNKNOWN | 0 | 4000 | IU | ||||||||
| 126788611 | 12678861 | 8 | C | ANTRA | OMEPRAZOLE | 1 | Intravenous (not otherwise specified) | 80.0MG UNKNOWN | 0 | 80 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126788611 | 12678861 | 1 | Bacterial infection |
| 126788611 | 12678861 | 2 | Bacterial infection |
| 126788611 | 12678861 | 3 | Vomiting |
| 126788611 | 12678861 | 4 | Bacterial infection |
| 126788611 | 12678861 | 5 | Bacterial infection |
| 126788611 | 12678861 | 6 | Increased upper airway secretion |
| 126788611 | 12678861 | 7 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126788611 | 12678861 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126788611 | 12678861 | Gamma-glutamyltransferase increased | |
| 126788611 | 12678861 | Hyperamylasaemia | |
| 126788611 | 12678861 | Hyperbilirubinaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126788611 | 12678861 | 1 | 20160628 | 20160706 | 0 | |
| 126788611 | 12678861 | 3 | 20160628 | 20160706 | 0 | |
| 126788611 | 12678861 | 4 | 20160628 | 20160729 | 0 | |
| 126788611 | 12678861 | 5 | 20160629 | 20160706 | 0 |